What did PulsePoint announce on July 23, 2026 related to WPP and HCP2DTC Influence™?

PulsePoint announced the first agency activation of its HCP2DTC Influence™ solution with CMI Media Group. According to PulsePoint, this deployment connects healthcare provider intelligence with direct-to-consumer marketing, initially for a leading oncology brand, unifying physician and patient campaigns within one programmatic strategy.

PulsePoint and CMI Media Group Launch the First Agency Activation of HCP2DTC Influence™

Rhea-AI Impact

(High)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

PulsePoint announced the first agency activation of its HCP2DTC Influence™ solution, which connects healthcare provider intelligence to direct-to-consumer marketing at scale. CMI Media Group is the inaugural agency partner, deploying the offering for a leading oncology brand to align physician and patient campaigns within a unified programmatic strategy.

Market Context

A director purchased 75,000 WPP shares on May 21, 2026, adding insider-buying context to this activa...

Analysis

A director purchased 75,000 WPP shares on May 21, 2026, adding insider-buying context to this activation. Historical partnership reactions were mixed, so execution and commercial uptake remain relevant risks to monitor.

Key Figures

Agency activation: First

1 metrics

Agency activation First HCP2DTC Influence™

Historical Context

5 past events · Latest: Jul 01 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 01	AI expansion plans	Positive	+5.0%	WPP outlined expansion plans for its AI-driven enterprise solutions business.
Jun 18	AWS collaboration agreement	Positive	-1.6%	WPP Enterprise Solutions signed a multi-year strategic collaboration agreement with AWS.
Apr 07	AI platform launch	Positive	+2.4%	Ogilvy launched an AI platform to identify and refer online racial hate speech.
Mar 13	Brand campaign launch	Positive	-0.2%	VML created a North American brand campaign for bet365 across multiple media channels.
Feb 10	Sports media partnership	Positive	+3.0%	Genius Sports partnered with WPP Media to launch a sports advertising intelligence tool.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent WPP news reactions were mixed, with positive responses to three announcements and negative responses to two.

Key Terms

hcp, programmatic

2 terms

hcp medical

"Yet that intelligence has historically stopped at the HCP campaign."

An HCP (healthcare professional) is a licensed medical practitioner—such as a doctor, nurse, pharmacist or clinician—who diagnoses, treats and advises patients. For investors, HCPs are important because their prescribing choices and treatment recommendations directly affect product sales and market uptake, acting like gatekeepers whose preferences and acceptance can determine a therapy’s commercial success and regulatory exposure.

programmatic technical

"within a unified programmatic strategy."

"Programmatic" describes the automated process of buying and selling financial assets or advertising space using computer systems and algorithms. It allows transactions to happen quickly and efficiently, often without human intervention, similar to how vending machines dispense snacks automatically. For investors, programmatic methods can lead to faster decision-making and more precise targeting of opportunities, potentially enhancing overall investment performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

07/23/2026 - 10:01 AM

NEWARK, N.J., July 23, 2026 /PRNewswire/ -- PulsePoint, the leading healthcare marketing platform, today announced the first agency activation of HCP2DTC Influence™, its proprietary solution connecting healthcare provider intelligence to direct-to-consumer activation at scale. CMI Media Group is the inaugural agency partner, deploying the innovative solution across a leading oncology brand to bridge physician and patient marketing.

Pharmaceutical marketers have long built sophisticated first-party understanding of the healthcare professionals most critical to their brands. Yet that intelligence has historically stopped at the HCP campaign. HCP2DTC Influence™ eliminates that barrier by enabling brands to leverage their physician strategy to inform patient engagement and bring HCP and DTC marketing together in a way that has not previously been possible.

"The disconnect between HCP and DTC programs has been one of pharma media's most persistent blind spots," said Andrew Stark, Chief Commercial Officer at PulsePoint. "CMI Media Group immediately recognized the opportunity to bridge that gap and became the first agency to activate HCP2DTC Influence™. This is an important milestone as we continue expanding the solution with additional agency and pharmaceutical partners."

"Strategic synergies between DTC and HCP are critical to campaign success and patient outcomes, and we're excited at PulsePoint delivering on this capability," said Justin Freid, Group President, Media, at CMI Media Group. "We're proud to be the first agency to bring HCP2DTC Influence™ to market and unlock this solution for our clients."

This deployment marks the first agency commercial activation of HCP2DTC Influence™ and validates the solution's ability to drive measurable impact across both HCP and DTC audiences within a unified programmatic strategy. PulsePoint will continue expanding our suite of HCP2DTC Influence™ innovations with our clients and partners.

About PulsePoint
PulsePoint is an award-winning advertising technology platform purpose-built for the demands of pharmaceutical and health marketing. Combining first-party clinical-grade data, omnichannel activation, and outcome-linked measurement, PulsePoint enables brands to engage the right healthcare professionals and patients with the right message at the right moment and prove it is working. Learn more at www.pulsepoint.com/

About CMI Media Group
CMI Media Group, a WPP company (NYSE: WPP, http://www.wpp.com), is a global, full-service media agency focused solely on health, wellness, and pharmaceutical marketing. CMI Media Group's core offerings include Audience Strategy, Planning, Development, and Insights; Data and Analytics; Buying and Investment; and Direct Response and Customer Experience. As the leading media resource for the world's top healthcare companies, CMI Media Group brings together leading technology, data, and talent to deliver seamless capabilities for clients. CMI Media Group has been recognized as a leader in inclusivity, talent retention and employee development as well as one of the industry's best places to work. To apply for a position within our teams visit https://www.cmimediagroup.com/careers/

View original content to download multimedia:https://www.prnewswire.com/news-releases/pulsepoint-and-cmi-media-group-launch-the-first-agency-activation-of-hcp2dtc-influence-302832784.html

SOURCE PulsePoint

FAQ

What is HCP2DTC Influence™ and how does it work for PulsePoint and WPP investors?

HCP2DTC Influence™ is a PulsePoint solution that links healthcare provider data to direct-to-consumer activation. According to PulsePoint, it lets pharmaceutical brands use existing physician strategies to inform patient engagement, reducing the historical disconnect between HCP campaigns and consumer marketing programs in one scalable platform.

Who is the first agency partner for PulsePoint's HCP2DTC Influence™ solution linked to WPP (WPP)?

CMI Media Group is the inaugural agency partner for PulsePoint’s HCP2DTC Influence™ solution. According to PulsePoint, CMI Media Group is deploying the technology across a leading oncology brand to bridge physician and patient marketing and bring HCP and DTC programs into a unified strategy.

How does the PulsePoint and CMI Media Group collaboration impact pharma marketing strategies for WPP-related businesses?

The collaboration introduces a unified approach connecting HCP and DTC media strategies. According to PulsePoint, CMI Media Group’s activation of HCP2DTC Influence™ enables pharmaceutical brands to extend existing HCP insights into patient outreach, addressing a long-standing separation between physician-focused and consumer-focused campaigns.

What future plans does PulsePoint have for expanding HCP2DTC Influence™ that may interest WPP shareholders?

PulsePoint plans to expand its suite of HCP2DTC Influence™ innovations with additional agency and pharmaceutical partners. According to PulsePoint, this first agency commercial activation is described as validating the solution’s ability to drive measurable impact across both HCP and DTC audiences within one programmatic strategy.